NasdaqCM:VKTXBiotechs
Is It Too Early Or Too Late To Consider Viking Therapeutics (VKTX) At US$35.53?
If you are wondering whether Viking Therapeutics at US$35.53 is still attractively priced or already reflecting high expectations, the next sections will walk through what the numbers suggest about its current valuation.
The stock has posted returns of 2.5% over the last 7 days, 22.5% over the last 30 days, 0.3% year to date and 20.6% over the last year. This naturally raises questions about how much future upside or risk is now embedded in the price.
Recent share price moves have been...